|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28.10.25 - 16:18
|
Apollo′s Kleinman on KDP Investment, PE Market and AI (Bloomberg)
|
|
|
Apollo Asset Management co-President Scott Kleinman discusses why the firm and KKR are helping to finance Keurig Dr Pepper's purchase of JDE Peet's NV. Speaking on “Bloomberg Open Interest,” Kleinman also comments on the current state of the PE market environment and AI....
|
|
|
|
|
27.10.25 - 19:01
|
Bloomberg Open Interest 10/27/2025 (Bloomberg)
|
|
|
Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." Trade optimism is in the air. Global stocks rally on news US and Chinese negotiators find common ground on a range of issues. The bull market faces a make-or-break week with tech powerhouse earnings on deck, plus a Fed decision due Wednesday. Deals, deals, deals - Huntington scoops up a smaller rival, Nelson Peltz eyes a Janus Henderson buyout while Keurig Dr Pepper lands funding for JDE Peet's from Apollo and KKR. And Qualcomm takes aim at Nvidia, unveiling new AI chips. (Source: Bloomberg)...
|
|
|
27.10.25 - 16:30
|
Kaffee-Comeback: Keurig Dr Pepper mit starkem Q3: Aktie reagiert sofort! (Wallstreet-Online)
|
|
|
Keurig Dr Pepper hebt seine Jahresziele nach starkem Quartal an. Die Aktie legt zu. Im Fokus steht jetzt die Übernahme von JDE Peet's, die Anleger zugleich begeistert und beunruhigt. Im dritten Quartal erzielte Keurig Dr Pepper einen Umsatz von 4,3 Milliarden US-Dollar und übertraf damit die durchschnittliche Analystenschätzung von 4,1 Milliarden US-Dollar deutlich. Vorstandschef Timothy Cofer sprach in einer Mitteilung von "robustem Wachstum" im US-Geschäft mit Erfrischungsgetränken und "ermutigenden Fortschritten" im Kaffeesegment. Besonders bemerkenswert: Die Kaffeeerlöse in den USA legten um 1,5 Prozent zu – der erste Zuwachs nach zehn rückläufigen Quartalen..
|
|
|
27.10.25 - 16:01
|
Keurig Dr Pepper Soars; Carter′s Falls; Avidity Biosciences Rallies (Bloomberg)
|
|
|
On this episode of Stock Movers with Lisa Mateo:
- Keurig Dr Pepper (KDP) shares soared ahead of the New York open after the company announced it now expects fiscal 2025 constant currency net sales growth in a high-single-digit range, revised from a mid-single-digit growth outlook previously. KDP also announced it is raising $7 billion from Apollo and KKR to help finance its acquisition of JDE Peet's NV, aiming to ease investor concerns about taking on too much debt.
- Carter's (CRI) shares fall ahead of the open after the children's apparel company reported net sales for the third quarter that missed the average analyst estimate. The company also plans to reduce offices-based roles by about 15% by the end of 2025, and it boosted the amount of stores it plans to close.
- Avidity Biosciences (RNA) shares rally in premarket trading after Novartis (NOVN) agreed to buy the biotechnology company in a deal valued at $12 billion. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
